GlassScriptPhysician profile
Japera N Levine
NPI 1164671632
$2,052.88
in general payments reported to CMS, 2019-2025
12 companies · $12.44 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $204 · 2021: $13.04 · 2022: $1,749 · 2023: $74.81 · 2025: $12.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $1,507.96 | 2022 | |
| Organogenesis INC. | $147.01 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $74.30 | 2020 | |
| Nevro Corp. | $60.93 | 2022-2023 | Senza |
| Heron Therapeutics, INC. | $49.35 | 2022 | |
| Medical Device Business Services, INC. | $43.88 | 2020 | |
| Melinta Therapeutics, LLC | $42.72 | 2020-2021 | |
| Treace Medical Concepts, INC. | $39.23 | 2022 | |
| Stryker Corporation | $37.22 | 2023 | Spy-Phi System |
| Medela LLC | $20.26 | 2022 | |
| Cashflow Solutions, LLC | $17.58 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Osteoremedies, LLC | $12.44 | 2025 | Osteoboost Select 5cc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Japera Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.